Summary: Addressing Current Questions and Emerging Considerations with the Use of PARP Inhibitors in the Management of Ovarian Cancer. An Independent CME Satellite Symposium During the Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer. Featuring Robert L Coleman, MD, Professor Jonathan A Ledermann, Stephanie Lheureux, MD, PhD and Kathleen Moore, MD. Moderated by Neil Love, MD. Produced by Research To Practice.
